Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

BGS-2019: a new GMPS inhibitor for the treatment of lupus nephritis

Nov. 4, 2019

Heterozygous COL4A1 mutations are a potential autosomal dominant cause of CAKUT

Oct. 25, 2019

Hypertensive rats are more sensitive to TRPM8-mediated relaxation of the pudendal artery

Oct. 25, 2019

Testosterone replacement cells a step closer

Oct. 16, 2019

Evaluating gepotidacin in the treatment of uncomplicated urinary tract infections: a phase IIa study

Oct. 8, 2019

Equillium initiates phase Ib study of itolizumab in lupus nephritis

Oct. 2, 2019

Dual CB1R/iNOS antagonist MRI-1867 ameliorates obesity-induced CKD in vivo

Sep. 27, 2019

Senolytics work as advertised

Sep. 25, 2019

Finding a balance in treating diabetic kidney damage

Sep. 23, 2019

Novel glomerulus-on-a-chip for renal disease modeling and drug testing

Sep. 23, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...